ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study

Top Cited Papers

Open Access

1 October 2006

journal article
research article
Published by American Medical Association (AMA) in Archives of Neurology

Vol. 63 (10) , 1402-1408
https://doi.org/10.1001/archneur.63.10.1402

Abstract

Alzheimer disease (AD) is severely debilitating. The onset is insidious, with loss of episodic memory as an early indicator of the disease. The currently approved drugs have a small but statistically significant symptomatic effect on cognition, behavior, and activities of daily living, but they do not affect the underlying disease process.

Keywords

This publication has 18 references indexed in Scilit:

A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model
Journal of Neuroscience, 2005
Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model
Neuron, 2004
Recovery of brain docosahexaenoate leads to recovery of spatial task performance
Journal of Neurochemistry, 2003
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Archives of Neurology, 2003
Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case–control study
British Journal of Nutrition, 2003
Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats
Neuroscience, 1999
Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: a comparison of sardine oil diet with palm oil diet
Mechanisms of Ageing and Development, 1998
Regional Membrane Phospholipid Alterations in Alzheimer's Disease
Neurochemical Research, 1998
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Annals of Neurology, 1997
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Lipids, 1991